These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2972473)

  • 61. Treatment of trichomonal vaginitis with a single dose of tinidazole.
    Weidenbach A; Leix H
    Curr Med Res Opin; 1974; 2(3):147-52. PubMed ID: 4407700
    [No Abstract]   [Full Text] [Related]  

  • 62. Prevalence, incidence, natural history, and response to treatment of Trichomonas vaginalis infection among adolescent women.
    Van Der Pol B; Williams JA; Orr DP; Batteiger BE; Fortenberry JD
    J Infect Dis; 2005 Dec; 192(12):2039-44. PubMed ID: 16288365
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of vaginal trichomonadosis with nifuratel.
    Schmidt H; Soost HJ
    Wiad Parazytol; 1969; 15(3):373-6. PubMed ID: 5349972
    [No Abstract]   [Full Text] [Related]  

  • 64. Recalcitrant Trichomonas vaginalis infection--a case series.
    Waters LJ; Dave SS; Deayton JR; French PD
    Int J STD AIDS; 2005 Jul; 16(7):505-9. PubMed ID: 16004634
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A comparative study of genotoxic effects in the treatment of trichomonas vaginalis infection: metronidazole or nalidixic acid.
    Akyol D; Mungan T; Baltaci V
    Arch Gynecol Obstet; 2000 Jul; 264(1):20-3. PubMed ID: 10985613
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Double blind study of a new trichomonicidal drug of exclusively oral use. Preliminary report].
    Rubio Lotvin B; Ruiz Moreno JA; De Larios NM; Bolio Arista R
    Ginecol Obstet Mex; 1973 Oct; 34(204):397-400. PubMed ID: 4590808
    [No Abstract]   [Full Text] [Related]  

  • 67. Nitrimidazine in the treatment of Trichomonas vaginalis vaginitis.
    Cohen L
    Br J Vener Dis; 1971 Jun; 47(3):177-8. PubMed ID: 4996964
    [No Abstract]   [Full Text] [Related]  

  • 68. [Critical evaluation of contemporary treatment of trichomoniasis (author's transl)].
    Valent M; Catár G
    Cesk Gynekol; 1973 Sep; 38(8):601-2. PubMed ID: 4765131
    [No Abstract]   [Full Text] [Related]  

  • 69. Management of metronidazole-resistant Trichomonas vaginalis--a new approach.
    Mammen-Tobin A; Wilson JD
    Int J STD AIDS; 2005 Jul; 16(7):488-90. PubMed ID: 16004628
    [TBL] [Abstract][Full Text] [Related]  

  • 70. European guideline for the management of vaginal discharge.
    Sherrard J;
    Int J STD AIDS; 2001 Oct; 12 Suppl 3():73-7. PubMed ID: 11589802
    [No Abstract]   [Full Text] [Related]  

  • 71. Trichomonas vaginalis. V. Further observations on metronidazole (Flagyl) (including infant follow-up).
    Robinson SC; Mirchandani G
    Am J Obstet Gynecol; 1965 Oct; 93(4):502-5. PubMed ID: 5320766
    [No Abstract]   [Full Text] [Related]  

  • 72. [Paraendocervical route for metronidazole administration in complex treatment of chronic Trichomonas endocervicitis].
    Churakov AA; Skatin AV; Borisova LV; Malykhina ZV; Kulichenko AN; Suvorov AP
    Antibiot Khimioter; 2004; 49(2):11-3. PubMed ID: 15285407
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Flunidazole--a new drug for systemic treatment of urogenital trichomoniasis.
    Pereyra AJ; Nelson RM; Ludders DJ
    Am J Obstet Gynecol; 1972 Apr; 112(7):963-6. PubMed ID: 4557646
    [No Abstract]   [Full Text] [Related]  

  • 74. Metronidazole in pregnancy.
    Peterson WF; Stauch JE; Ryder CD
    Am J Obstet Gynecol; 1966 Feb; 94(3):243-9. PubMed ID: 5905047
    [No Abstract]   [Full Text] [Related]  

  • 75. Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection.
    Moraes ME; Cunha GH; Bezerra MM; Fechine FV; Pontes AV; Andrade WS; Frota Bezerra FA; Moraes MO; Cavalcanti PP
    Arch Gynecol Obstet; 2012 Jul; 286(1):125-30. PubMed ID: 22350328
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Trichopol treatment of pregnant women suffering from genital trichomoniasis].
    Genyk IA
    Vopr Okhr Materin Det; 1973 Sep; 18(9):80-2. PubMed ID: 4783954
    [No Abstract]   [Full Text] [Related]  

  • 77. [Criteria of clinical evaluation of antitrichomonal agents].
    Kurnatowska A
    Wiad Parazytol; 1979; 25(3):253-7. PubMed ID: 316618
    [No Abstract]   [Full Text] [Related]  

  • 78. [Early results of treatment of women infected with Trichomonas vaginalis cured with the preparations atrican (TC 109) and hamycin].
    Komorowska A
    Wiad Parazytol; 1969; 15(3):433-5. PubMed ID: 5349988
    [No Abstract]   [Full Text] [Related]  

  • 79. [The efficacy of established, systemically active trichomonacidal agents in the infection model tri-chomonas vaginalis/rat (author's transl)].
    Meingassner JG; Mieth H
    Arzneimittelforschung; 1977; 27(3):638-9. PubMed ID: 577434
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treatment of sexually transmitted vaginosis/vaginitis.
    Lossick JG
    Rev Infect Dis; 1990; 12 Suppl 6():S665-81. PubMed ID: 2201078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.